U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H5N5O
Molecular Weight 151.1261
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Guanine

SMILES

NC1=NC2=C(N=CN2)C(=O)N1

InChI

InChIKey=UYTPUPDQBNUYGX-UHFFFAOYSA-N
InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)

HIDE SMILES / InChI

Molecular Formula C5H5N5O
Molecular Weight 151.1261
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters.
2001-04
Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase.
2001-04
A-like guanine-guanine stacking in the aqueous DNA duplex of d(GGGGCCCC).
2001-03-23
Structure, folding and activity of the VS ribozyme: importance of the 2-3-6 helical junction.
2001-03-15
Affinity of mismatch-binding protein MutS for heteroduplexes containing different mismatches.
2001-03-15
Solution structure of an A-tract DNA bend.
2001-03-09
Characterization of cDNA encoding the human tRNA-guanine transglycosylase (TGT) catalytic subunit.
2001-03-07
The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents.
2001-03-07
Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage.
2001-03-01
Conjugative metabolism of 1,2-dibromoethane in mitochondria: disruption of oxidative phosphorylation and alkylation of mitochondrial DNA.
2001-03-01
A seminested PCR test for simultaneous detection of two common mutations (35delG and 167delT) in the connexin-26 gene.
2001-03
Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid.
2001-03
New biochemical markers in Alzheimer disease.
2001-03
Substrate assisted catalysis -- application to G proteins.
2001-03
Metabolic fate of AMP, IMP, GMP and XMP in the cytosol of rat brain: an experimental and theoretical analysis.
2001-03
Metabolism of the beta-oxidized intermediates of N-nitrosodi-n-propylamine: N-nitroso-beta-hydroxypropylpropylamine and N-nitroso-beta-oxopropylpropylamine.
2001-03
Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
2001-03
Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system.
2001-03
Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging.
2001-03
Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine.
2001-03
Cloning and direct G-protein regulation of phospholipase D from tobacco.
2001-02-26
Characterization of the mouse liver fructose-1,6-bisphosphatase gene.
2001-02-21
Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
2001-02-16
Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism.
2001-02-15
Specific binding of 2-amino-1,8-naphthyridine into a single guanine bulge as evidenced by photooxidation of GG doublet.
2001-02-12
Oxidation kinetics of guanine in DNA molecules adsorbed onto indium tin oxide electrodes.
2001-02-01
Miscoding and misincorporation of 8-oxo-guanine during leading and lagging strand synthesis in Escherichia coli.
2001-02
Gemcitabine and Pemetrexed disodium in treating breast cancer.
2001-02
Alanine scan mutagenesis of the switch I domain of the Caulobacter crescentus CgtA protein reveals critical amino acids required for in vivo function.
2001-02
The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
2001-02
Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
2001-02
Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer.
2001-02
Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
2001-02
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.
2001-02
Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication".
2001-01-29
The N-terminal domain of the Caulobacter crescentus CgtA protein does not function as a guanine nucleotide exchange factor.
2001-01-26
Genetic study of SOX9 in a case of campomelic dysplasia.
2001-01-15
DNA electrochemical biosensors.
2001-01-01
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.
2001-01-01
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
2001-01-01
Enhanced loop DNA folding induced by thymine-CH3 group contact and perpendicular guanine-thymine interaction.
2001-01
Evidence of a no-effect level in silica-induced rat lung mutagenicity but not in fibrogenicity.
2001-01
Quantum chemistry predicted correlations between geometric isomerism (conformation) of -OH and =NH substituents and typical group frequencies of nucleic acid bases: cytosine.
2001-01
Reduction of wobble-position GC bases in Corynebacteria genes and enhancement of PCR and heterologous expression.
2001-01
Spreadsheet-based program for the analysis of DNA methylation.
2001-01
Guanine versus deoxyribose damage in DNA oxidation mediated by vanadium(IV) and vanadium(V) complexes.
2001-01
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals.
2001
Regulation of gene expression by GC-rich DNA cis-elements.
2001
Sequence-specific DNA damage induced by UVA radiation in the presence of endogenous and exogenous photosensitizers.
2001
Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:22:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:22:18 GMT 2025
Record UNII
5Z93L87A1R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CI 75170
INCI  
INCI  
Preferred Name English
Guanine
HSDB   INCI   MI   USP-RS  
INCI  
Official Name English
GUANINE [EP IMPURITY]
Common Name English
2-AMINOHYPOXANTHINE
Common Name English
2-AMINO-1,7-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]
Systematic Name English
GANCICLOVIR IMPURITY F [EP IMPURITY]
Common Name English
C.I. NO. 75170 (GUANINE)
Common Name English
6H-PURIN-6-ONE, 2-AMINO-1,7-DIHYDRO-
Systematic Name English
VALGANCICLOVIR HYDROCHLORIDE IMPURITY B [USP IMPURITY]
Common Name English
GUANINE [USP IMPURITY]
Common Name English
VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY A [EP IMPURITY]
Common Name English
ACICLOVIR IMPURITY B [EP IMPURITY]
Common Name English
GUANINE [WHO-IP]
Common Name English
GUANINE [USP-RS]
Common Name English
GUANINE [HSDB]
Common Name English
ACICLOVIR IMPURITY B [WHO-IP]
Common Name English
GUANINE [MI]
Common Name English
VALACICLOVIR HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Common Name English
Classification Tree Code System Code
LOINC 78695-4
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
NCI_THESAURUS C786
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
LOINC 79690-4
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
LOINC 79663-1
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
Code System Code Type Description
MERCK INDEX
m5869
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY Merck Index
DRUG BANK
DB02377
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
CAS
73-40-5
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
HSDB
2127
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
RS_ITEM_NUM
1302156
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
FDA UNII
5Z93L87A1R
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
MESH
D006147
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
PUBCHEM
135398634
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
RXCUI
1372539
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
GUANINE
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
SMS_ID
100000182768
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID9052476
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
CHEBI
16235
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
NCI_THESAURUS
C532
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-799-8
Created by admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
PRIMARY
Related Record Type Details
DERIVATIVE -> PARENT
Related Record Type Details
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
Related Record Type Details
ACTIVE MOIETY